: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Lung Cancer

Free Subscription

Articles published in J Thorac Oncol
Retrieve available abstracts of 535 articles:
HTML format
Text format

Single Articles

February 2012

SHAO N , Jin S, Zhu W
An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.
J Thorac Oncol. 2012;7:470-2.
PubMed Text format Related articles

D'ANTONIO C , Viterbo A, Romiti A, Enrici MM, et al
Complete Regression of a Non-small Cell Lung Cancer Choroidal Metastasis with Intravitreal Bevacizumab.
J Thorac Oncol. 2012;7:468-469.
PubMed Text format Related articles

MATSUO Y , Shibuya K, Nagata Y, Norihisa Y, et al
Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
J Thorac Oncol. 2012;7:453-6.
PubMed Text format Related articles Abstract available

ZWITTER M
Dutch statistics on lung cancer: sobering experience for a new approach.
J Thorac Oncol. 2012;7:269-71.
PubMed Text format Related articles

January 2012

SIEGFRIED JM , Gubish CT, Rothstein ME, Henry C, et al
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

GUCKENBERGER M , Kestin LL, Hope AJ, Belderbos J, et al
Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

LEE GW , Go SI, Cho YJ, Jeong YY, et al
Hypoxia-Inducible Factor-1alpha and Excision Repair Cross-Complementing 1 in Patients with Small Cell Lung Cancer Who Received Front-Line Platinum-Based Chemotherapy: A Retrospective Study.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

NAITO T , Tanaka F, Ono A, Yoneda K, et al
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

JANSSEN-HEIJNEN ML , van Steenbergen LN, Steyerberg E, Visser O, et al
Long-Term Excess Mortality for Survivors of Non-small Cell Lung Cancer in the Netherlands.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

MACHTAY M , Paulus R, Moughan J, Komaki R, et al
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma: A Radiation Therapy Oncology Group Analysis.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

FENG Y , Thiagarajan PS, Ma PC
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

DZIADZIUSZKO R , Wynes MW, Singh S, Bernadette Reyna A, et al
Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

WEICKHARDT A , Doebele R, Oton A, Lettieri J, et al
A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

LIU G , Cheng D, Ding K, Le Maitre A, et al
Pharmacogenetic Analysis of BR.21, a Placebo-Controlled Randomized Phase III Clinical Trial of Erlotinib in Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2012.
PubMed Text format Related articles Abstract available

SUBRAMANIAN J , Waqar SN, Morgensztern D, Govindan R, et al
Recent Advances in Lung Cancer: Summary of Presentations from the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2011.
J Thorac Oncol. 2012;7:260-5.
PubMed Text format Related articles Abstract available

LASKIN J , Crino L, Felip E, Franke F, et al
Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer: Safety of Avastin in Lung trial (MO19390).
J Thorac Oncol. 2012;7:203-211.
PubMed Text format Related articles Abstract available

FIELD JK , Smith RA, Aberle DR, Oudkerk M, et al
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report.
J Thorac Oncol. 2012;7:10-19.
PubMed Text format Related articles Abstract available

SOLOMON B , Shaw AT
Are Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer Prognostic, Predictive, or Both?
J Thorac Oncol. 2012;7:5-7.
PubMed Text format Related articles

December 2011

HASSELLE MD , Haraf DJ, Rusthoven KE, Golden DW, et al
Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MAEDA R , Ishii G, Ito M, Hishida T, et al
Number of Circulating Endothelial Progenitor Cells and Intratumoral Microvessel Density in Non-small Cell Lung Cancer Patients: Differences in Angiogenic Status between Adenocarcinoma Histologic Subtypes.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LASKIN JJ , Nicholas G, Lee C, Gitlitz B, et al
Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GITLITZ BJ , Tsao-Wei DD, Groshen S, Davies A, et al
A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KREBS MG , Hou JM, Sloane R, Lancashire L, et al
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HUNG JJ , Jeng WJ, Hsu WH, Huang BS, et al
Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

OSAROGIAGBON RU , Allen JW, Farooq A, Wu JT, et al
Objective Review of Mediastinal Lymph Node Examination in a Lung Cancer Resection Cohort.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BELANI CP , Wu YL, Chen YM, Kim JH, et al
Efficacy and Safety of Pemetrexed Maintenance Therapy versus Best Supportive Care in Patients from East Asia with Advanced, Nonsquamous Non-small Cell Lung Cancer: An Exploratory Subgroup Analysis of a Global, Randomized, Phase 3 Clinical Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

OSHIRO Y , Mizumoto M, Okumura T, Hashimoto T, et al
Results of Proton Beam Therapy without Concurrent Chemotherapy for Patients with Unresectable Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEN YM , Tsai CM, Fan WC, Shih JF, et al
Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VAN DER DRIFT MA , Karim-Kos HE, Siesling S, Groen HJ, et al
Progress in Standard of Care Therapy and Modest Survival Benefits in the Treatment of Non-small Cell Lung Cancer Patients in the Netherlands in the Last 20 Years.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KIM YH , Mishima M
How Should We Use Bevacizumab in Patients with Non-small Cell Lung Cancer?
J Thorac Oncol. 2011;6:2145-2146.
PubMed Text format Related articles

OU SH , Azada M, Dy J, Stiber JA, et al
Asymptomatic Profound Sinus Bradycardia (Heart Rate </=45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib.
J Thorac Oncol. 2011;6:2135-2137.
PubMed Text format Related articles Abstract available

SCHMIDT LH , Spieker T, Koschmieder S, Humberg J, et al
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth.
J Thorac Oncol. 2011;6:1984-1992.
PubMed Text format Related articles Abstract available

LALLY BE , Wagner H, Langer C, Thomas CR Jr, et al
Assessing Patient Accrual to Cooperative Group Lung Cancer Trials: Why Are Rates Disappointing?
J Thorac Oncol. 2011;6:1971-1973.
PubMed Text format Related articles

KAWAHARA M , Kubo A, Komuta K, Fujita Y, et al
A Phase I Study of Amrubicin and Fixed Dose of Irinotecan (CPT-11) in Relapsed Small Cell Lung Cancer: Japan Multinational Trial Organization LC0303.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

November 2011

MINAMI-SHIMMYO Y , Ohe Y, Yamamoto S, Sumi M, et al
Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

YANG P , Cheville AL, Wampfler JA, Garces YI, et al
Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VEST MT , Tanoue L, Soulos PR, Kim AW, et al
Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HOU J , Lambers M, den Hamer B, den Bakker MA, et al
Expression Profiling-Based Subtyping Identifies Novel Non-small Cell Lung Cancer Subgroups and Implicates Putative Resistance to Pemetrexed Therapy.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

NADLER E , Forsyth M, Satram-Hoang S, Reyes C, et al
Costs and Clinical Outcomes among Patients with Second-Line Non-small Cell Lung Cancer in the Outpatient Community Setting.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MOLLER A , Sartipy U
Predictors of Postoperative Quality of Life after Surgery for Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

YAMADA T , Takeuchi S, Kita K, Bando H, et al
Hepatocyte Growth Factor Induces Resistance to Anti-epidermal Growth Factor Receptor Antibody in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MORRIS PG , Reiner AS, Szenberg OR, Clarke JL, et al
Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

OKUMURA S , Sasaki T, Minami Y, Ohsaki Y, et al
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MAHAFFEY CM , Mahaffey NC, Holland W, Zhang H, et al
Aberrant Regulation of the MRP3 Gene in Non-small Cell Lung Carcinoma.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PELOSI G , Fabbri A, Bianchi F, Maisonneuve P, et al
DeltaNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

OKAMOTO I , Yoshioka H, Takeda K, Satouchi M, et al
Phase I Clinical Study of the Angiogenesis Inhibitor TSU-68 Combined with Carboplatin and Paclitaxel in Chemotherapy-Naive Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

JANSSEN-HEIJNEN ML , Karim-Kos HE, van der Drift MA, Groen HJ, et al
Modest Improvements of Survival for Patients with Small Cell Lung Cancer Aged 45 to 59 Years Only, Diagnosed in the Netherlands, 1989 to 2008.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ROELOFS E , Engelsman M, Rasch C, Persoon L, et al
Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MAZZONE PJ , Wang XF, Xu Y, Mekhail T, et al
Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

YANO S , Yamada T, Takeuchi S, Tachibana K, et al
Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEN YT , Chang JW, Liu HP, Yu TF, et al
Clinical Implications of High MET Gene Dosage in Non-Small Cell Lung Cancer Patients without Previous Tyrosine Kinase Inhibitor Treatment.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GIRAUD P , Morvan E, Claude L, Mornex F, et al
Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BONGERS EM , Haasbeek CJ, Lagerwaard FJ, Slotman BJ, et al
Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ICHINOSE Y , Seto T, Sasaki T, Yamanaka T, et al
S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706).
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHUETTE W , Nagel S, von Weikersthal LF, Pabst S, et al
Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer: The APRONTA Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LUDOVINI V , Floriani I, Pistola L, Minotti V, et al
Association of Cytidine Deaminase and Xeroderma Pigmentosum Group D Polymorphisms with Response, Toxicity, and Survival in Cisplatin/Gemcitabine-Treated Advanced Non-small Cell Lung Cancer Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CROMWELL I , van der Hoek K, Melosky B, Peacock S, et al
Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

AMBROGI MC , Fanucchi O, Cioni R, Dini P, et al
Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MICKE P , Edlund K, Holmberg L, Kultima HG, et al
Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1833-1840.
PubMed Text format Related articles Abstract available

WILSON DO , Leader JK, Weissfeld J
Quantitative computed tomography analysis of emphysema and lung cancer risk.
J Thorac Oncol. 2011;6:1965-6.
PubMed Text format Related articles

SMITH BM
Quantitative computed tomography analysis of emphysema and lung cancer risk.
J Thorac Oncol. 2011;6:1965.
PubMed Text format Related articles

GALETTA D , Silvestris N, Catino A, Colucci G, et al
Peripheral Skin Edema as Unusual Toxicity in Three Patients with Advanced Non-small Cell Lung Cancer Treated with Pemetrexed Alone or in Combination with Cisplatin.
J Thorac Oncol. 2011;6:1964.
PubMed Text format Related articles

KOCZYWAS M , Cristea MC
Osteonecrosis of the Humeral Head in a Patient with Non-small Cell Lung Cancer Receiving Bevacizumab.
J Thorac Oncol. 2011;6:1960-1.
PubMed Text format Related articles

ARRIETA O , Cardona AF, Federico Bramuglia G, Gallo A, et al
Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America.
J Thorac Oncol. 2011;6:1955-1959.
PubMed Text format Related articles Abstract available

WEBER B , Sorensen BS, Knap MM, Madsen HH, et al
Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib.
J Thorac Oncol. 2011;6:1946-9.
PubMed Text format Related articles Abstract available

RODRIGUES-PEREIRA J , Kim JH, Magallanes M, Lee DH, et al
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1907-1914.
PubMed Text format Related articles Abstract available

EVANS WK , Wolfson MC
Computed Tomography Screening for Lung Cancer without a Smoking Cessation Program-Not a Cost-Effective Idea.
J Thorac Oncol. 2011;6:1781-3.
PubMed Text format Related articles

TSAO AS , Heymach J
Mesothelioma and small cell lung cancer.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

IYENGAR P , Choy H
Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncology.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

UJHAZY P , Carbone D
Summary of presentations from the 11th targeted therapies for lung cancer meeting: immunotherapy and vaccines for treatment of lung cancer.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

CUFFE S , Leighl NB
Targeting the Phosphatidylinosital 3-Kinase, Akt, and Mammalian Target of Rapamycin Pathway in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

RIESS JW , Neal JW
Targeting FGFR, Ephrins, Mer, MET, and PDGFR-alpha in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

SUBRAMANIAN J , Waqar SN, Govindan R
Targeted therapy in lung cancer: lessons learned from past experiences.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

SOMAIAH N , Simon GR
Molecular targeted agents and biologic therapies for lung cancer.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

GOVINDAN R
Summary of presentation from the targeted therapy in lung cancer meeting.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles Abstract available

October 2011

GONZALEZ M , Vignaud JM, Clement-Duchene C, Luc A, et al
Smoking, Occupational Risk Factors, and Bronchial Tumor Location: A Possible Impact for Lung Cancer Computed Tomography Scan Screening.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GRIDELLI C , Gallo C, Morabito A, Iaffaioli RV, et al
Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KOZAK KR , Milne GL, Bentzen SM, Yock TI, et al
Elevation of Prostaglandin E2 in Lung Cancer Patients with Digital Clubbing.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHAO YY , Xue C, Jiang W, Zhao HY, et al
Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KWON YJ , Lee SJ, Koh JS, Kim SH, et al
Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHUETTE W , Krzakowski MJ, Massuti B, Otterson GA, et al
Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PIETANZA MC , Lynch TJ Jr, Lara PN Jr, Cho J, et al
XL647-A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BRAILLON A
Vinflunine for Non-small Cell Lung Cancer: Realistic Hopes?
J Thorac Oncol. 2011;6:1777.
PubMed Text format Related articles

TOURANI JM
Reply to the Letter to the Editor Entitled "Vinflunine for Non-small Cell Lung Cancer: Realistic Hopes?".
J Thorac Oncol. 2011;6:1777-8.
PubMed Text format Related articles

VARLOTTO JM , Medford-Davis LN, Recht A, Flickinger JC, et al
Large Cell Neuroendocrine Lung Cancer: The Strength of Large Databases and the Need for Prospective Trials.
J Thorac Oncol. 2011;6:1776.
PubMed Text format Related articles

SEM LIEW M , Arulananda S, Seow J, Mitchell P, et al
Bronchoepidural Fistula in a Man with Actinomycosis Complicated Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1761-2.
PubMed Text format Related articles

BAGGSTROM MQ , Qi Y, Koczywas M, Argiris A, et al
A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1757-1760.
PubMed Text format Related articles Abstract available

YOSHIDA A , Tsuta K, Nitta H, Hatanaka Y, et al
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas.
J Thorac Oncol. 2011;6:1677-86.
PubMed Text format Related articles Abstract available

NAKAMURA T , Sueoka-Aragane N, Iwanaga K, Sato A, et al
A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.
J Thorac Oncol. 2011;6:1639-48.
PubMed Text format Related articles Abstract available

ROSSI G , Mengoli MC, Cavazza A
Pulmonary large cell neuroendocrine carcinoma: a true high-grade neuroendocrine tumor needing prospective therapeutic data.
J Thorac Oncol. 2011;6:1775.
PubMed Text format Related articles

ASAMURA H
Identity, similarity, and difference between large cell neuroendocrine carcinoma and small cell carcinoma.
J Thorac Oncol. 2011;6:1774.
PubMed Text format Related articles

VALLIERES E , Van Houtte P, Travis WD, Rami-Porta R, et al
Carcinoma in situ at the bronchial resection margin: a review.
J Thorac Oncol. 2011;6:1617-23.
PubMed Text format Related articles Abstract available

CHIU CH , Yeh YC, Lin KH, Wu YC, et al
Histological subtypes of lung adenocarcinoma have differential (1)F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
J Thorac Oncol. 2011;6:1697-703.
PubMed Text format Related articles Abstract available

HORNBECH K , Ravn J, Steinbruchel DA
Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002-2006.
J Thorac Oncol. 2011;6:1733-40.
PubMed Text format Related articles Abstract available

STERLACCI W , Tzankov A, Veits L, Zelger B, et al
A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas.
J Thorac Oncol. 2011;6:1649-57.
PubMed Text format Related articles Abstract available

GROGAN EL , Weinstein JJ, Deppen SA, Putnam JB Jr, et al
Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease.
J Thorac Oncol. 2011;6:1720-5.
PubMed Text format Related articles Abstract available

September 2011

MOLLER A , Sartipy U
Associations Between Changes in Quality of Life and Survival After Lung Cancer Surgery.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LAZZARI C , Spreafico A, Bachi A, Roder H, et al
Changes in Plasma Mass-Spectral Profile in Course of Treatment of Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HATLEN P , Gronberg BH, Langhammer A, Carlsen SM, et al
Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

EDELMAN MJ , Hodgson L, Wang X, Christenson R, et al
Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SAJI H , Tsuboi M, Yoshida K, Kato Y, et al
Prognostic Impact of Number of Resected and Involved Lymph Nodes at Complete Resection on Survival in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEN CP , Weinberg VK, Jahan TM, Jablons DM, et al
Implications of Delayed Initiation of Radiotherapy: Accelerated Repopulation after Induction Chemotherapy for Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VINAYANUWATTIKUN C , Sriuranpong V, Tanasanvimon S, Chantranuwat P, et al
Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VANSTEENKISTE J , Solomon B, Boyer M, Wolf J, et al
Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy: A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SAGERUP CM , Smastuen M, Johannesen TB, Helland A, et al
Increasing Age and Carcinoma Not Otherwise Specified: A 20-Year Population Study of 40,118 Lung Cancer Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GOTO K , Ichinose Y, Ohe Y, Yamamoto N, et al
Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SPIGEL DR , Hainsworth JD, Shipley DL, Ervin TJ, et al
A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PRIM N , Quoix E, Beau-Faller M
Tumor Cell Content for Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1615-1616.
PubMed Text format Related articles

JANKU F , Garrido-Laguna I, Petruzelka LB, Stewart DJ, et al
Novel Therapeutic Targets in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1601-12.
PubMed Text format Related articles Abstract available

FRAIOLI F , Vetere S, Anile M, Venuta F, et al
Computed tomography perfusion: a new method to evaluate response to therapy in lung cancer.
J Thorac Oncol. 2011;6:1599-600.
PubMed Text format Related articles

THU KL , Chari R, Lockwood WW, Lam S, et al
miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer.
J Thorac Oncol. 2011;6:1594-8.
PubMed Text format Related articles Abstract available

ASAMURA H
Surgery after induction chemotherapy or chemoradiotherapy for locally advanced lung cancer: a technical challenge.
J Thorac Oncol. 2011;6:1458-9.
PubMed Text format Related articles

CALMAN L , Beaver K, Hind D, Lorigan P, et al
Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-Analysis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

RIAZ SP , Horton M, Kang J, Mak V, et al
Lung Cancer Incidence and Survival in England: An Analysis by Socioeconomic Deprivation and Urbanization.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BURMEISTER BH , Michael M, Burmeister E, Cox S, et al
A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy: Trans Tasman Radiation Oncology Study TROG 03.07.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MCMAHON PM , Kong CY, Bouzan C, Weinstein MC, et al
Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BECKER S , Markova B, Wiewrodt R, Hoffarth S, et al
Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HAASBEEK CJ , Lagerwaard FJ, Slotman BJ, Senan S, et al
Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TSAO AS , Liu S, Fujimoto J, Wistuba II, et al
Phase II Trials of Imatinib Mesylate and Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

AZUMA K , Okamoto I, Kawahara A, Taira T, et al
Association of the Expression of Mutant Epidermal Growth Factor Receptor Protein as Determined with Mutation-Specific Antibodies in Non-small Cell Lung Cancer with Progression-Free Survival after Gefitinib Treatment.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DE GIORGI U , Fanini F, Amadori D, Cancellieri A, et al
Tumorlets in familial history of bronchopulmonary carcinoid.
J Thorac Oncol. 2011;6:1613-4.
PubMed Text format Related articles

TAKAHASHI Y , Ishii G, Taira T, Fujii S, et al
Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.
J Thorac Oncol. 2011;6:1460-7.
PubMed Text format Related articles Abstract available

WAHIDI MM , Unroe MA, Adlakha N, Beyea M, et al
The use of electrocautery as the primary ablation modality for malignant and benign airway obstruction.
J Thorac Oncol. 2011;6:1516-20.
PubMed Text format Related articles Abstract available

August 2011

VAN'T WESTEINDE SC , de Koning HJ, Thunnissen FB, Oudkerk M, et al
The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SHEPHERD FA , Douillard JY, Blumenschein GR Jr
Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ROBINSON BM , Kennedy C, McLean J, McCaughan BC, et al
Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SALTO-TELLEZ M , Tsao MS, Shih JY, Thongprasert S, et al
Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ZELIADT SB , Sekaran NK, Hu EY, Slatore CC, et al
Comparison of Demographic Characteristics, Surgical Resection Patterns, and Survival Outcomes for Veterans and Nonveterans with Non-small Cell Lung Cancer in the Pacific Northwest.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LIU L , Wu C, Wang Y, Zhong R, et al
Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SIGEL CS , Moreira AL, Travis WD, Zakowski MF, et al
Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HASEGAWA Y , Kawaguchi T, Kubo A, Ando M, et al
Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy: A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DE PAS T , Toffalorio F, Manzotti M, Fumagalli C, et al
Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

AZZOLI CG , Patel JD, Krug LM, Miller V, et al
Pralatrexate with Vitamin Supplementation in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer: Safety and Efficacy in a Phase 1 Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

WITT C
European respiratory society/american thoracic society/international association for the study of lung cancer international multidisciplinary classification of lung adenocarcinoma: state of the art.
J Thorac Oncol. 2011;6:1451.
PubMed Text format Related articles

KLEMPNER SJ , Cohen DW, Costa DB
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers.
J Thorac Oncol. 2011;6:1439-40.
PubMed Text format Related articles

AHMED S , Birnbaum AE, Safran HP, Dipetrillo TA, et al
Pathologic Response After Neoadjuvant Carboplatin and Weekly Paclitaxel for Early-Stage Lung Cancer: A Brown University Oncology Group Phase II Study.
J Thorac Oncol. 2011;6:1432-4.
PubMed Text format Related articles Abstract available

HONG YJ , Hur J, Lee HJ, Nam JE, et al
Analysis of Tumor Markers in the Cytological Fluid Obtained from Computed Tomography-Guided Needle Aspiration Biopsy for the Diagnosis of Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1330-5.
PubMed Text format Related articles Abstract available

RICE D , Rusch V, Pass H, Asamura H, et al
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Inte
J Thorac Oncol. 2011;6:1304-1312.
PubMed Text format Related articles Abstract available

SUZUKI K
JCOG0201 defined "radiological early peripheral lung adenocarcinoma".
J Thorac Oncol. 2011;6:1452-3.
PubMed Text format Related articles

DETTERBECK FC
Sublobar resection of ground glass opacity--great data, but can I have more?
J Thorac Oncol. 2011;6:1451-2.
PubMed Text format Related articles

TURAKA A , Parsons RB
A rare complication of a CT-guided biopsy.
J Thorac Oncol. 2011;6:1438.
PubMed Text format Related articles

RIELY GJ , Johnson ML, Medina C, Rizvi NA, et al
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.
J Thorac Oncol. 2011;6:1435-7.
PubMed Text format Related articles Abstract available

CASIRAGHI M , De Pas T, Maisonneuve P, Brambilla D, et al
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
J Thorac Oncol. 2011;6:1373-8.
PubMed Text format Related articles Abstract available

July 2011

THU KL , Pikor LA, Chari R, Wilson IM, et al
Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PANKRATZ VS , Sun Z, Aakre J, Li Y, et al
Systematic Evaluation of Genetic Variants in Three Biological Pathways on Patient Survival in Low-Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BARNETT SA , Rusch VW, Zheng J, Park BJ, et al
Contemporary Results of Surgical Resection of Non-small Cell Lung Cancer After Induction Therapy: A Review of 549 Consecutive Cases.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEN G , Kim S, Taylor JM, Wang Z, et al
Development and Validation of a Quantitative Real-Time Polymerase Chain Reaction Classifier for Lung Cancer Prognosis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LI W , Li B, Giacalone NJ, Torossian A, et al
BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non-small Cell Lung Carcinoma In Vitro.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TSE LA , Yu IT, Qiu H, Au JS, et al
Lung Cancer Decreased Sharply in First 5 Years After Smoking Cessation in Chinese Men.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ROSSI A , Torri V, Gridelli C
Switch Maintenance versus Second-Line Treatment in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1298.
PubMed Text format Related articles

SINGH N
Classification of Large Cell Neuroendocrine Carcinoma: At the Cross Roads of Small and Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:1298-9.
PubMed Text format Related articles

WEBER B , Winterdahl M, Memon A, Sorensen BS, et al
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor.
J Thorac Oncol. 2011;6:1287-9.
PubMed Text format Related articles Abstract available

STEWART DJ , Erasmus JJ
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor.
J Thorac Oncol. 2011;6:1149-51.
PubMed Text format Related articles

MORGENSZTERN D , Govindan R
A roundup of recently published articles relevant to thoracic oncology.
J Thorac Oncol. 2011;6:1295-7.
PubMed Text format Related articles Abstract available

NAKANO T , Shimizu K, Takahashi T, Mohara J, et al
Pulmonary large cell carcinoma mimicking an infected thoracoabdominal aortic aneurysm.
J Thorac Oncol. 2011;6:1293-4.
PubMed Text format Related articles

SHORT MA , Lam S, McWilliams AM, Ionescu DN, et al
Using laser Raman spectroscopy to reduce false positives of autofluorescence bronchoscopies: a pilot study.
J Thorac Oncol. 2011;6:1206-14.
PubMed Text format Related articles Abstract available

June 2011

SUN JM , Han J, Ahn JS, Park K, et al
Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Peterman AH, Lee CB, Moore DT, et al
A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age >/=70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

METIN M , Citak N, Sayar A, Pekcolaklar A, et al
The Role of Extended Cervical Mediastinoscopy in Staging of Non-small Cell Lung Cancer of the Left Lung and a Comparison with Integrated Positron Emission Tomography and Computed Tomography: Does Integrated Positron Emission Tomography and Computed To
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TANIZAKI J , Okamoto I, Okamoto K, Takezawa K, et al
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

RAMALINGAM SS , Davies AM, Longmate J, Edelman MJ, et al
Bortezomib for Patients with Advanced-Stage Bronchioloalveolar Carcinoma: A California Cancer Consortium Phase II Study (NCI 7003).
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ELLIS PM , Blais N, Soulieres D, Ionescu DN, et al
A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Bogart J, Veeramachaneni NK, Kratzke R, et al
Annual Review of Advances in Non-small Cell Lung Cancer Research: A Report for the Year 2010.
J Thorac Oncol. 2011.
PubMed Text format Related articles

KNEIP C , Schmidt B, Seegebarth A, Weickmann S, et al
SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

YOSHIMASU T , Oura S, Ohta F, Hirai Y, et al
Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SATOH H , Inoue A, Kobayashi K, Maemondo M, et al
Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SANDLER A , Graham C, Baggstrom M, Herbst R, et al
An Open-Label, Multicenter, Three-Stage, Phase II Study of S-1 in Combination with Cisplatin as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LV YL , Yuan DM, Wang K, Miao XH, et al
Diagnostic Performance of Integrated Positron Emission Tomography/Computed Tomography for Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer: A Bivariate Systematic Review and Meta-Analysis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VON BARTHELD MB , Versteegh MI, Braun J, Willems LN, et al
Transesophageal Ultrasound-Guided Fine-Needle Aspiration for the Mediastinal Restaging of Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

RYU JS , Shin ES, Nam HS, Yi HG, et al
Differential Effect of Polymorphisms of CMPK1 and RRM1 on Survival in Advanced Non-small Cell Lung Cancer Patients Treated with Gemcitabine or Taxane/Cisplatinum.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VAN DER MEIJ BS , Phernambucq EC, Fieten GM, Smit EF, et al
Nutrition During Trimodality Treatment in Stage III Non-small Cell Lung Cancer: Not Only Important for Underweight Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KIM KW , Speirs CK, Jung DK, Lu B, et al
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LEE JO , Kim TM, Lee SH, Kim DW, et al
Anaplastic Lymphoma Kinase Translocation: A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MATTIOLI S , Ruffato A, Puma F, Daddi N, et al
Does Anatomical Segmentectomy Allow an Adequate Lymph Node Staging for cT1a Non-small Cell Lung Cancer?
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SUN J , Garfield DH, Lam B, Yan J, et al
The Value of Autofluorescence Bronchoscopy Combined with White Light Bronchoscopy Compared with White Light Alone in the Diagnosis of Intraepithelial Neoplasia and Invasive Lung Cancer: A Meta-Analysis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

AMIN NP , Miften M, Kavanagh B, Raben D, et al
Impact of Induction Chemotherapy on Estimated Risk of Radiation Pneumonitis in Small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SEO SK , Jin HO, Woo SH, Kim YS, et al
Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GOTTLIN EB , Bentley RC, Campa MJ, Pisetsky DS, et al
The Association of Intratumoral Germinal Centers with Early-Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

RUSSELL PA , Wainer Z, Wright GM, Daniels M, et al
Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung A
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

NAMENDYS-SILVA SA
Critical care for patients with lung cancer.
J Thorac Oncol. 2011;6:1144.
PubMed Text format Related articles

MCGRATH EE
The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL?
J Thorac Oncol. 2011;6:983-7.
PubMed Text format Related articles Abstract available

BOGART JA
Split-Course Radiotherapy for Poor-Risk Stage III Lung Cancer: Striking the Right Balance or History Regurgitated?
J Thorac Oncol. 2011;6:975-7.
PubMed Text format Related articles

ROSSI A , Galetta D, Bottiglieri L, Stufano V, et al
Evaluation of ALK gene status in primary lung adenocarcinoma and matched metastases.
J Thorac Oncol. 2011;6:1146.
PubMed Text format Related articles

HATA A , Fujita S, Kaji R, Katakami N, et al
Do complex mutations of the epidermal growth factor receptor gene reflect intratumoral heterogeneity?
J Thorac Oncol. 2011;6:1144-6.
PubMed Text format Related articles

DALLAS JL , Jantz MA, Lightsey JL, Sonntag C, et al
Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.
J Thorac Oncol. 2011;6:1142-3.
PubMed Text format Related articles

JOHNSON ML , Riely GJ, Rizvi NA, Azzoli CG, et al
Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib.
J Thorac Oncol. 2011;6:1128-31.
PubMed Text format Related articles Abstract available

LI C , Sun Y, Fang Z, Han X, et al
Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.
J Thorac Oncol. 2011;6:1016-21.
PubMed Text format Related articles Abstract available

PARK ER , Japuntich S, Temel J, Lanuti M, et al
A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.
J Thorac Oncol. 2011;6:1059-65.
PubMed Text format Related articles Abstract available

TSAI CM , Au JS, Chang GC, Cheng AC, et al
Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.
J Thorac Oncol. 2011;6:1092-7.
PubMed Text format Related articles Abstract available

HSU KH , Chen KC, Yang TY, Yeh YC, et al
Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
J Thorac Oncol. 2011;6:1066-72.
PubMed Text format Related articles Abstract available

CHEN YM , Fan WC, Tsai CM, Liu SH, et al
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy.
J Thorac Oncol. 2011;6:1110-6.
PubMed Text format Related articles Abstract available

May 2011

KENMOTSU H , Naito T, Kimura M, Ono A, et al
The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

OTSUKA S , Klimowicz AC, Kopciuk K, Petrillo SK, et al
CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DAHELE M , Palma D, Lagerwaard F, Slotman B, et al
Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DIACONESCU R , Lafond C, Whittom R
Treatment Delays in Non-small Cell Lung Cancer and Their Prognostic Implications.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

FORCE J , Rajan A, Dombi E, Steinberg SM, et al
Assessment of Objective Responses Using Volumetric Evaluation in Advanced Thymic Malignancies and Metastatic Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

NOVELLO S , Camps C, Grossi F, Mazieres J, et al
Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

WILSON DO , Leader JK, Fuhrman CR, Reilly JJ, et al
Quantitative Computed Tomography Analysis, Airflow Obstruction, and Lung Cancer in the Pittsburgh Lung Screening Study.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SAWABATA N , Miyaoka E, Asamura H, Nakanishi Y, et al
Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TOURNOUX-FACON C , Senellart H, Lemarie E, Tourani JM, et al
Phase I and Pharmacokinetic Study of IV Vinflunine in Combination with Gemcitabine for Treatment of Advanced Non-small Cell Lung Cancer in Chemonaive Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SUDA K , Tomizawa K, Fujii M, Murakami H, et al
Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SELINGER CI , Cooper WA, Al-Sohaily S, Mladenova DN, et al
Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHNEIDER T , Hoffmann H, Dienemann H, Schnabel PA, et al
Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TAN EH , Goss GD, Salgia R, Besse B, et al
Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

KIM H , Yoo SB, Choe JY, Paik JH, et al
Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein Expression.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DARLING GE , Maziak DE, Inculet RI, Gulenchyn KY, et al
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

YU CT , Hsia JY, Hseih YC, Su LJ, et al
The Novel Protein Suppressed in Lung Cancer Down-Regulated in Lung Cancer Tissues Retards Cell Proliferation and Inhibits the Oncokinase Aurora-A.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

VARLOTTO JM , Medford-Davis LN, Recht A, Flickinger JC, et al
Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GOULD MK , Schultz EM, Wagner TH, Xu X, et al
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
J Thorac Oncol. 2011;6:875-883.
PubMed Text format Related articles Abstract available

STEWART DJ
Chemotherapy Dose Intensity and Survival in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:971.
PubMed Text format Related articles

NADAL E , Bruna J, de Olza MO, Antonio M, et al
Paraneoplastic opsoclonus-myoclonus syndrome as a new and single manifestation of relapsing disease in a patient with small cell lung cancer.
J Thorac Oncol. 2011;6:968-9.
PubMed Text format Related articles

ABRAO FC , Sabbion RO, Canzian M, Fernandez A, et al
Isolated Epithelioid Trophoblastic Tumor Mimicking Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:966-7.
PubMed Text format Related articles

O'MAHAR SE , Campbell TC, Hoang T, Seo S, et al
Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:951-3.
PubMed Text format Related articles Abstract available

HELLAND A , Skaug HM, Kleinberg L, Iversen ML, et al
EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery.
J Thorac Oncol. 2011;6:947-950.
PubMed Text format Related articles Abstract available

OU SH , Kwak EL, Siwak-Tapp C, Dy J, et al
Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification.
J Thorac Oncol. 2011;6:942-946.
PubMed Text format Related articles Abstract available

KOZAK MM , Murphy JD, Schipper ML, Donington JS, et al
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
J Thorac Oncol. 2011;6:920-6.
PubMed Text format Related articles Abstract available

PREDINA JD , Puc MM, Bergey MR, Sonnad SS, et al
Improved survival after pulmonary metastasectomy for soft tissue sarcoma.
J Thorac Oncol. 2011;6:913-9.
PubMed Text format Related articles Abstract available

GOUNANT V , Fleury-Feith J
How do we do it?: another optimal methodology for endobronchial ultrasound sample handling.
J Thorac Oncol. 2011;6:972-3.
PubMed Text format Related articles

KORPANTY G , Mulligan N, Carney DN
Complete radiological response of metastatic anaplastic lymphoma kinase-positive signet ring lung adenocarcinoma to systemic chemotherapy.
J Thorac Oncol. 2011;6:963-5.
PubMed Text format Related articles

BERG A , Brustugun OT, Lund-Iversen M, Helland A, et al
Palmar bullous blistering induced by erlotinib.
J Thorac Oncol. 2011;6:954.
PubMed Text format Related articles

MOK TS , Lam KC
The diverse diversity.
J Thorac Oncol. 2011;6:842-3.
PubMed Text format Related articles

KOH Y , Kim DW, Kim TM, Lee SH, et al
Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.
J Thorac Oncol. 2011;6:905-12.
PubMed Text format Related articles Abstract available

April 2011

BEAU-FALLER M , Degeorges A, Rolland E, Mounawar M, et al
Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status fo
J Thorac Oncol. 2011.
PubMed Text format Related articles

CAI XW , Shedden KA, Yuan SH, Davis MA, et al
Baseline Plasma Proteomic Analysis to Identify Biomarkers that Predict Radiation-Induced Lung Toxicity in Patients Receiving Radiation for Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles

DIGUMARTI R , Wang Y, Raman G, Doval DC, et al
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles

HAN B , Xiu Q, Wang H, Shen J, et al
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles

SHAO H , Tang H, Salavaggione OE, Yu C, et al
Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles

GIELDA BT , Marsh JC, Zusag TW, Faber LP, et al
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles

SOO RA , Loh M, Mok TS, Ou SH, et al
Ethnic Differences in Survival Outcome in Patients with Advanced Stage Non-small Cell Lung Cancer: Results of a Meta-Analysis of Randomized Controlled Trials.
J Thorac Oncol. 2011.
PubMed Text format Related articles

PELOSI G , Rossi G, Bianchi F, Maisonneuve P, et al
Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagn
J Thorac Oncol. 2011.
PubMed Text format Related articles

SCHNEIDER BJ , Gadgeel SM, Ramnath N, Wozniak AJ, et al
Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles

MAKINSON A , Tenon JC, Eymard-Duvernay S, Pujol JL, et al
Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer: Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort Study.
J Thorac Oncol. 2011.
PubMed Text format Related articles

CUFFE S , Moua T, Summerfield R, Roberts H, et al
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers.
J Thorac Oncol. 2011;6:818-22.
PubMed Text format Related articles Abstract available

TREASURE T , Macbeth F
Response to the article "pulmonary resection for metastatic gastric cancer" by kemp et Al.
J Thorac Oncol. 2011;6:836.
PubMed Text format Related articles

KOHNO T , Kunitoh H, Mimaki S, Shiraishi K, et al
Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma.
J Thorac Oncol. 2011;6:813-7.
PubMed Text format Related articles Abstract available

March 2011

TAKIGAWA N , Kiura K, Segawa Y, Hotta K, et al
Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GADGEEL SM , Ruckdeschel JC, Patel BB, Wozniak A, et al
Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SOLASSOL J , Maudelonde T, Mange A, Pujol JL, et al
Clinical Relevance of Autoantibody Detection in Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DAVIDOFF AJ , Gardner JF, Seal B, Edelman MJ, et al
Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

Abstracts of the 3rd Australian Lung Cancer Conference (ALCC). Melbourne, Australia. October 6-9, 2010.
J Thorac Oncol. 2011;6.
PubMed Text format Related articles

HATA A , Kaji R, Fujita S, Katakami N, et al
High-dose Erlotinib for Refractory Brain Metastases in a Patient with Relapsed Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:653-4.
PubMed Text format Related articles

KIM YH , Ishii G, Ochiai A
Excision repair cross-complementing-1 for small cell lung cancer.
J Thorac Oncol. 2011;6:652.
PubMed Text format Related articles

ROSSI G , Nannini N, Tiseo M
Excision repair cross-complementing-1 for small cell lung cancer.
J Thorac Oncol. 2011;6:652.
PubMed Text format Related articles

OKUDA C , Kim YH, Takeuchi K, Togashi Y, et al
Successful treatment with pemetrexed in a patient with mucinous bronchioloalveolar carcinoma: long-term response duration with mild toxicity.
J Thorac Oncol. 2011;6:641-2.
PubMed Text format Related articles

COTE ML , Haddad R, Edwards DJ, Atikukke G, et al
Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:627-630.
PubMed Text format Related articles Abstract available

CAMIDGE DR , Hirsch FR, Varella-Garcia M, Franklin WA, et al
Finding ALK-Positive Lung Cancer: What Are We Really Looking for?
J Thorac Oncol. 2011;6:411-3.
PubMed Text format Related articles

MIZOTA A , Shitara K, Fukui T
Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea.
J Thorac Oncol. 2011;6:651-2.
PubMed Text format Related articles

DETTERBECK FC
On plain language and going astray.
J Thorac Oncol. 2011;6:650.
PubMed Text format Related articles

MADDIPATLA S , Pennock G, Magill MJ Jr, Nasser NM, et al
A rare case of endobronchial amelanotic melanoma.
J Thorac Oncol. 2011;6:643-4.
PubMed Text format Related articles

LE MAIGNAN L , Mirebeau-Prunier D, Vervueren L, Jeanfaivre T, et al
First case of A859T epidermal growth factor receptor mutation responding to erlotinib.
J Thorac Oncol. 2011;6:639-40.
PubMed Text format Related articles

SENGSAYADETH S , Montgomery J, Pao W
T4 or MI?
J Thorac Oncol. 2011;6:632.
PubMed Text format Related articles

LEE SH , Park CM, Goo JM, Lee HJ, et al
Persistent part-solid nodule in the lung represents pulmonary adenocarcinoma.
J Thorac Oncol. 2011;6:631.
PubMed Text format Related articles

D'ANGELO SP , Kris MG, Pietanza MC, Rizvi NA, et al
A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed.
J Thorac Oncol. 2011;6:624-6.
PubMed Text format Related articles Abstract available

DETTERBECK FC
Maintaining aim at a moving target.
J Thorac Oncol. 2011;6:417-22.
PubMed Text format Related articles

VERONESI G , Maisonneuve P, Pelosi G, Casiraghi M, et al
Screening-detected lung cancers: is systematic nodal dissection always essential?
J Thorac Oncol. 2011;6:525-30.
PubMed Text format Related articles Abstract available

TSELIS N , Ferentinos K, Kolotas C, Schirren J, et al
Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
J Thorac Oncol. 2011;6:545-52.
PubMed Text format Related articles Abstract available

SCHNEIDER T , Kimpfler S, Warth A, Schnabel PA, et al
Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
J Thorac Oncol. 2011;6:432-8.
PubMed Text format Related articles Abstract available

OSAROGIAGBON RU , Phelps G, McFarlane J, Bankole O, et al
Causes and consequences of deviation from multidisciplinary care in thoracic oncology.
J Thorac Oncol. 2011;6:510-6.
PubMed Text format Related articles Abstract available

February 2011

ANDREWS TD , Baird JW, Wallace WA, Harrison DJ, et al
Routinely Obtained Diagnostic Material as a Source of RNA for Personalized Medicine in Lung Cancer Patients.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

XU X , Sun PL, Li JZ, Jheon S, et al
Aberrant Wnt1/beta-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CAMIDGE DR , Kono SA, Lu X, Okuyama S, et al
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DE PAS TM , Toffalorio F, Giovannetti E, Radice D, et al
Optimizing Pemetrexed-Gemcitabine Combination in Patients with Advanced Non-small Cell Lung Cancer: A Pharmacogenetic Approach.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MINEGISHI Y , Kuribayashi H, Kitamura K, Mizutani H, et al
The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GREENSPOON JN , Evans WK, Cai W, Wright JR, et al
Selecting Patients with Extensive-Stage Small Cell Lung Cancer for Prophylactic Cranial Irradiation by Predicting Brain Metastases.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SUN Y , Moretti L, Giacalone NJ, Schleicher S, et al
Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SINGH-GUPTA V , Joiner MC, Runyan L, Yunker CK, et al
Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SUZUKI K , Koike T, Asakawa T, Kusumoto M, et al
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201).
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PEPEK JM , Chino JP, Marks LB, D'amico TA, et al
How Well does the New Lung Cancer Staging System Predict for Local/Regional Recurrence After Surgery?: A Comparison of the TNM 6 and 7 Systems.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GOVINDAN R , Morgenzstern D, Kommor MD, Herbst RS, et al
Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ZENG X , Hood BL, Zhao T, Conrads TP, et al
Lung Cancer Serum Biomarker Discovery Using Label-Free Liquid Chromatography-Tandem Mass Spectrometry.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

JIANG J , Liang X
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy.
J Thorac Oncol. 2011;6:408.
PubMed Text format Related articles

GUO S , Liang Y, Zhou Q
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy.
J Thorac Oncol. 2011;6:406-8.
PubMed Text format Related articles

ROSSI G , Cavazza A
Histologic Type Definition in Clinical Trials on Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:405.
PubMed Text format Related articles

GARFIELD DH , Franklin W
Dramatic response to pemetrexed in a patient with pneumonic-type mucinous bronchioloalveolar carcinoma.
J Thorac Oncol. 2011;6:397-8.
PubMed Text format Related articles

TIBALDI C , Giovannetti E, Vasile E, Boldrini L, et al
Inherited Germline T790M Mutation and Somatic Epidermal Growth Factor Receptor Mutations in Non-small Cell Lung Cancer Patients.
J Thorac Oncol. 2011;6:395-6.
PubMed Text format Related articles

KRUG LM , Crawford J, Ettinger DS, Shapiro GI, et al
Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer.
J Thorac Oncol. 2011;6:384-386.
PubMed Text format Related articles Abstract available

SIRERA R , Bremnes RM, Cabrera A, Jantus-Lewintre E, et al
Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011;6:286-290.
PubMed Text format Related articles Abstract available

TRAVIS WD , Brambilla E, Noguchi M, Nicholson AG, et al
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
J Thorac Oncol. 2011;6:244-85.
PubMed Text format Related articles Abstract available

SIMON GR , Silvestri GA
You Just Can't Call it Lung Cancer Anymore.
J Thorac Oncol. 2011;6:239-40.
PubMed Text format Related articles

RUSCH VW , Giroux DJ
Nodal staging in lung cancer: lymph node location or number?
J Thorac Oncol. 2011;6:237-8.
PubMed Text format Related articles

READY N , Karaseva NA, Orlov SV, Luft AV, et al
Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

EDELMAN MJ , Otterson G, Leach J, Malpass T, et al
Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BEPLER G , Dilling TJ, Wagner H, Hazelton T, et al
Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LO IACONO M , Monica V, Saviozzi S, Ceppi P, et al
p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HATA A , Kaji R, Fujita S, Katakami N, et al
Does the addition of vascular endothelial growth factor inhibitors to epidermal growth factor receptor-tyrosine kinase inhibitor overcome T790M acquired resistance?
J Thorac Oncol. 2011;6:404.
PubMed Text format Related articles

PELOSI G
The new taxonomy of lung adenocarcinoma stemming from a multidisciplinary integrated approach: novel pathology concepts and perspectives.
J Thorac Oncol. 2011;6:241-3.
PubMed Text format Related articles

January 2011

YI ES , Boland JM, Maleszewski JJ, Roden AC, et al
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-Small Cell Lung Carcinoma: IHC Score Algorithm for FISH.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

DECROISETTE C , Monnet I, Berard H, Quere G, et al
Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601).
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG JG , Guo JF, Liu DL, Liu Q, et al
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SRIRANGAM A , Milani M, Mitra R, Guo Z, et al
The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BOEHMER L , Waqar S, Butler S, Sezhiyan A, et al
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010): Focus on Supportive Care Issues Related to Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SOUBANI AO , Ruckdeschel JC
The Outcome of Medical Intensive Care for Lung Cancer Patients: The Case for Optimism.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

REKHTMAN N , Brandt SM, Sigel CS, Friedlander MA, et al
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SAKAO Y , Okumura S, Mingyon M, Uehara H, et al
The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

TSAI CM , Chen JT, Stewart DJ, Chiu CH, et al
Antagonism between Gefitinib and Cisplatin in Non-small Cell Lung Cancer Cells: Why Randomized Trials Failed?
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CAMPLING BG , Collins BN, Algazy KM, Schnoll RA, et al
Spontaneous Smoking Cessation Before Lung Cancer Diagnosis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

MAEDA R , Yoshida J, Ishii G, Hishida T, et al
The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

NIHO S , Kubota K, Yoh K, Goto K, et al
Clinical Outcome of Small Cell Lung Cancer with Pericardial Effusion but without Distant Metastasis.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

FOSS KM , Sima C, Ugolini D, Neri M, et al
miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

GROSE D , Devereux G, Brown L, Jones R, et al
Variation in Comorbidity and Clinical Management in Patients Newly Diagnosed with Lung Cancer in Four Scottish Centers.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

BIANCONI F , Pistola L, Chiari R, Minotti V, et al
Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SANLI T , Liu C, Rashid A, Hopmans SN, et al
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

PAIK JH , Choe G, Kim H, Choe JY, et al
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

NIZZOLI R , Tiseo M, Gelsomino F, Bartolotti M, et al
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

LIM G , Bezjak A, Higgins J, Moseley D, et al
Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

COATE LE , Massey C, Hope A, Sacher A, et al
Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

WEI S , Asamura H, Kawachi R, Sakurai H, et al
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification?
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

WEISSMAN CH , Reynolds CH, Neubauer MA, Pritchard S, et al
A Phase III Randomized Trial of Gemcitabine-Oxaliplatin versus Carboplatin-Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

HORGAN AM , Yang B, Azad AK, Amir E, et al
Pharmacogenetic and Germline Prognostic Markers of Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

SUBRAMANIAN J , Corrales L, Soulieres D, Morgensztern D, et al
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) Focus on Tumor Biology and Biomarkers Related to Lung Cancer.
J Thorac Oncol. 2011.
PubMed Text format Related articles Abstract available

CHRISTIANI DC
ERCC2/XPD Polymorphisms and Lung Cancer Risk.
J Thorac Oncol. 2011;6:233.
PubMed Text format Related articles

ZHAN P , Qian Q, Yu LK, Wei SZ, et al
ERCC2/XPD Polymorphisms and Lung Cancer Risk.
J Thorac Oncol. 2011;6:233-5.
PubMed Text format Related articles

STINCHCOMBE TE , Baggstrom MQ, Somaiah N, Simon GR, et al
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: Focus on Non-small Cell Lung Cancer (2010).
J Thorac Oncol. 2011;6:227-32.
PubMed Text format Related articles Abstract available

GRAEF S , Choo CG, Warfield A, Cullen M, et al
Small cell lung cancer in a 26-year-old man with significant cannabis exposure.
J Thorac Oncol. 2011;6:218-9.
PubMed Text format Related articles

HATA A , Fujita S, Katakami N, Sakai C, et al
Bilateral subdural hematoma associated with central nervous system metastases from lung cancer.
J Thorac Oncol. 2011;6:207-8.
PubMed Text format Related articles

SHIAO TH , Chang YL, Yu CJ, Chang YC, et al
Epidermal growth factor receptor mutations in small cell lung cancer: a brief report.
J Thorac Oncol. 2011;6:195-8.
PubMed Text format Related articles Abstract available

LI Y , Yang P
GPC5 Gene and Its Related Pathways in Lung Cancer.
J Thorac Oncol. 2011;6:2-5.
PubMed Text format Related articles

MORGENSZTERN D , Govindan R
Best of the month: A round up of articles published in recent months.
J Thorac Oncol. 2011;6:223-6.
PubMed Text format Related articles

ORTIZ TM , Cohen DW, Kent MS, Janne PA, et al
KRAS mutation analysis helps to differentiate between pulmonary metastasis from colon adenocarcinoma in situ and primary lung adenocarcinoma.
J Thorac Oncol. 2011;6:220-2.
PubMed Text format Related articles

NAKAJIMA T , Yasufuku K
How I do it--optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples.
J Thorac Oncol. 2011;6:203-6.
PubMed Text format Related articles

LAACK E , Simon R, Regier M, Andritzky B, et al
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.
J Thorac Oncol. 2011;6:199-202.
PubMed Text format Related articles

OSHITA F , Honda T, Murakami S, Kondo T, et al
Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.
J Thorac Oncol. 2011;6:128-31.
PubMed Text format Related articles

REINERSMAN JM , Johnson ML, Riely GJ, Chitale DA, et al
Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans.
J Thorac Oncol. 2011;6:28-31.
PubMed Text format Related articles

BLANCHARD EM , Moon J, Hesketh PJ, Kelly K, et al
Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.
J Thorac Oncol. 2011;6:115-20.
PubMed Text format Related articles

SHIONO S , Abiko M, Sato T
Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
J Thorac Oncol. 2011;6:43-7.
PubMed Text format Related articles

December 2010

HUANG CH , Williamson SK, Van Veldhuizen PJ, Hsueh CT, et al
Potential Role of Platelet-Derived Growth Factor Receptor Inhibition Using Imatinib in Combination with Docetaxel in the Treatment of Recurrent Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

INFANTE M , Chiesa G, Solomon D, Morenghi E, et al
Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography: Comparative Analysis in the Screening and Control Arm.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KUO YW , Jerng JS, Shih JY, Chen KY, et al
The Prognostic Value of the Simplified Comorbidity Score in the Treatment of Small Cell Lung Carcinoma.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NANGUZGAMBO AB , Aubeelack K, von Groote-Bidlingmaier F, Hattingh SM, et al
Radiologic Features, Staging, and Operability of Primary Lung Cancer in the Western Cape, South Africa: A 1-Year Retrospective Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

GERBER DE , Rasco DW, Le P, Yan J, et al
Predictors and Impact of Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer in the United States: Real-World Considerations for Maintenance Therapy.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LI Y , Krowka MJ, Qi Y, Katzmann JA, et al
Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

BREMNES RM , Al-Shibli K, Donnem T, Sirera R, et al
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

DESCOURT R , Vergnenegre A, Barlesi F, Lena H, et al
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced Non-small Cell Lung Cancer: The GFPC 05-03 Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KIM HK , Choi YS, Kim K, Shim YM, et al
Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron Emission Tomography and Computed Tomography.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

RUFFINI E , Asioli S, Filosso PL, Buffoni L, et al
Significance of the Presence of Microscopic Vascular Invasion After Complete Resection of Stage I-II pT1-T2N0 Non-small Cell Lung Cancer and Its Relation with T-Size Categories: Did the 2009 7th Edition of the TNM Staging System Miss Something?
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LEE JH , Song EM, Sim YS, Ryu YJ, et al
Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

YU YH , Liao CC, Hsu WH, Chen HJ, et al
Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

BAGGSTROM MQ , Waqar SN, Sezhiyan AK, Gilstrap E, et al
Barriers to Enrollment in Non-small Cell Lung Cancer Therapeutic Clinical Trials.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HIRSCHOWITZ EA , Mullins A, Prajapati D, Baeker T, et al
Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NAKAMURA Y , Soda H, Oka M, Kinoshita A, et al
Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

CASAS F , Vinolas N, Ferrer F, Agusti C, et al
Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation Paclitaxel-Carboplatin in Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

VERGNENEGRE A , Corre R, Berard H, Paillotin D, et al
Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SASAKI H , Hikosaka Y, Kawano O, Moriyama S, et al
Evaluation of Kras Gene Mutation and Copy Number Gain in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

OU SH , Bazhenova L, Camidge DR, Solomon BJ, et al
Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:2044-2046.
PubMed Text format Related articles

NAKAJIMA T , Kimura H, Takeuchi K, Soda M, et al
Treatment of Lung Cancer with an ALK Inhibitor After EML4-ALK Fusion Gene Detection Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
J Thorac Oncol. 2010;5:2041-3.
PubMed Text format Related articles

SCHULZE M , Spengler W, Horger M
Long-Lasting Drop in Perfusion of a Non-small Cell Lung Cancer Induced by Monotherapy with the Epithelial Growth Factor Receptor Inhibitor Erlotinib Persisting Despite Tumor Progression at Remote Sites.
J Thorac Oncol. 2010;5:2015-6.
PubMed Text format Related articles

JALAL S , Bedano P, Einhorn L, Bhatia S, et al
Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the hoosier oncology group.
J Thorac Oncol. 2010;5:2008-11.
PubMed Text format Related articles Abstract available

CHEN F , Matsuo Y, Yoshizawa A, Sato T, et al
Salvage Lung Resection for Non-small Cell Lung Cancer After Stereotactic Body Radiotherapy in Initially Operable Patients.
J Thorac Oncol. 2010;5:1999-2002.
PubMed Text format Related articles Abstract available

SOCINSKI MA , Raju RN, Stinchcombe T, Kocs DM, et al
Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1963-9.
PubMed Text format Related articles Abstract available

VOLLEBERGH MA , Kappers I, Klomp HM, Buning-Kager JC, et al
Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor Inhibitors in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1939-48.
PubMed Text format Related articles Abstract available

HOQUE MO , Brait M, Rosenbaum E, Poeta ML, et al
Genetic and Epigenetic Analysis of erbB Signaling Pathway Genes in Lung Cancer.
J Thorac Oncol. 2010;5:1887-93.
PubMed Text format Related articles Abstract available

MARCUS AI , Zhou W
LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis.
J Thorac Oncol. 2010;5:1883-6.
PubMed Text format Related articles Abstract available

BRADLEY J
New territory: surgical salvage for stereotactic body radiation therapy failures in lung cancer.
J Thorac Oncol. 2010;5:1879-80.
PubMed Text format Related articles

BADZIO A , Wynes MW, Dziadziuszko R, Merrick DT, et al
Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1905-1911.
PubMed Text format Related articles Abstract available

NANJUNDAN M , Byers LA, Carey MS, Siwak DR, et al
Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence.
J Thorac Oncol. 2010;5:1894-1904.
PubMed Text format Related articles Abstract available

HASANI A , Leighl NB
Targeting vascular endothelial growth factor in lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

UJHAZY P , Garon EB
Proapoptotic agents in lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

MORGENSZTERN D , Goodgame B, Govindan R
Vaccines and immunotherapy for non-small cell lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

CAMIDGE DR
Cell cycle-associated kinases as targets for therapy in lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

RAMALINGAM SS
Histone deacetylase, proteasome, and heat shock protein inhibitors for the treatment of lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

SOMAIAH N , Simon GR
Molecular targeted agents and biologic therapies for non-small cell lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

GOVINDAN R
Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

STINCHCOMBE TE , Socinski MA
Maintenance Therapy in Advanced Non-small Cell Lung Cancer: Current Status and Future Implications.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

O'CALLAGHAN DS , O'Donnell D, O'Connell F, O'Byrne KJ, et al
The role of inflammation in the pathogenesis of non-small cell lung cancer.
J Thorac Oncol. 2010;5:2024-36.
PubMed Text format Related articles Abstract available

CHOI YH , Lee JK, Kang HJ, Lee TS, et al
Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer.
J Thorac Oncol. 2010;5:1949-52.
PubMed Text format Related articles Abstract available

LIU L , Shao X, Gao W, Bai J, et al
The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
J Thorac Oncol. 2010;5:1922-32.
PubMed Text format Related articles Abstract available

JANG RW , Isogai PK, Mittmann N, Bradbury PA, et al
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.
J Thorac Oncol. 2010;5:1953-7.
PubMed Text format Related articles Abstract available

Abstracts of the Chicago Multidisciplinary Symposium in Thoracic Oncology. Chicago, Illinois, USA. December 9-11, 2010.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

Proceedings from the 10th Annual Meeting of Molecularly Targeted Therapy in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

EDELMAN MJ
EML4/ALK and ras inhibitors.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

ULLMANN CD
Cancer stem cells and targeting embryonic signaling pathways.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

DY G
Novel taxanes/epothilones.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

PAL SK , Reckamp KL
Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

DAS M , Wakelee H
Vascular disrupting agents.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

HALUSKA P
Insulin-like growth factor pathway.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

BAGGSTROM MQ , Govindan R
Radiotherapy.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

DY G
MEK/MAPK inhibitors.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

WITTA SE
Supportive care.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

BONOMI P
Epidermal growth factor receptor pathway.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

DY G
SRC inhibitors.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

KUO YW , Wu SG, Ho CC, Shih JY, et al
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.
J Thorac Oncol. 2010;5:2039-40.
PubMed Text format Related articles

NERI S , Takahashi Y, Terashi T, Hamakawa H, et al
Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
J Thorac Oncol. 2010;5:2003-7.
PubMed Text format Related articles Abstract available

VAN SCHIL PE
Salvage surgery after stereotactic radiotherapy: a new challenge for thoracic surgeons.
J Thorac Oncol. 2010;5:1881-2.
PubMed Text format Related articles

MUNDEN RF , Erasmus JJ, Wahba H, Fineberg NS, et al
Follow-up of small (4 mm or less) incidentally detected nodules by computed tomography in oncology patients: a retrospective review.
J Thorac Oncol. 2010;5:1958-62.
PubMed Text format Related articles Abstract available

November 2010

YUAN ST , Frey KA, Gross MD, Hayman JA, et al
Semiquantification and Classification of Local Pulmonary Function by V/Q Single Photon Emission Computed Tomography in Patients with Non-small Cell Lung Cancer: Potential Indication for Radiotherapy Planning.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SCAGLIOTTI G , Brodowicz T, Shepherd FA, Zielinski C, et al
Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

FAN WC , Yu CJ, Tsai CM, Huang MS, et al
Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

TAKIGUCHI Y , Seto T, Ichinose Y, Nogami N, et al
Long-Term Administration of Second-Line Chemotherapy with S-1 and Gemcitabine for Platinum-Resistant Non-small Cell Lung Cancer: A Phase II Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

BREMNES RM , Donnem T, Al-Saad S, Al-Shibli K, et al
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KNOEFEL LF , Werle-Schneider G, Dally H, Muller PJ, et al
Polymorphisms in the Apoptotic Pathway Gene BCL-2 and Survival in Small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HAINSWORTH JD , Fang L, Huang JE, Karlin D, et al
BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SUN Y , Giacalone NJ, Lu B
Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small Cell Lung Carcinoma.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

PAECH DC , Weston AR, Pavlakis N, Gill A, et al
A Systematic Review of the Interobserver Variability for Histology in the Differentiation between Squamous and Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SALIDO M , Pijuan L, Martinez-Aviles L, Galvan AB, et al
Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

TSAO MS , Sakurada A, Ding K, Aviel-Ronen S, et al
Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HARADA M , Hato T, Horio H
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

BRAHMER JR , Dahlberg SE, Gray RJ, Schiller JH, et al
Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-small Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SATO Y , Yamamoto N, Kunitoh H, Ohe Y, et al
Genome-Wide Association Study on Overall Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HOTTA K , Takigawa N, Kiura K
ILD during Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1878.
PubMed Text format Related articles

JONES SJ , Milenkova T
ILD during Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1877-8.
PubMed Text format Related articles

ROSSI G , Nannini N, Tiseo M
ERCC1 and Small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1876-7.
PubMed Text format Related articles

TOMIZAWA K , Suda K, Onozato R, Kuwano H, et al
Analysis of ERBB4 Mutations and Expression in Japanese Patients with Lung Cancer.
J Thorac Oncol. 2010;5:1859-61.
PubMed Text format Related articles Abstract available

NEAL JW , Heist RS, Fidias P, Temel JS, et al
Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy.
J Thorac Oncol. 2010;5:1855-8.
PubMed Text format Related articles Abstract available

BOFFA DJ , Detterbeck FC, Smith EJ, Rami-Porta R, et al
Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer?
J Thorac Oncol. 2010;5:1779-1783.
PubMed Text format Related articles Abstract available

DUNCAVAGE E , Goodgame B, Sezhiyan A, Govindan R, et al
Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1755-63.
PubMed Text format Related articles Abstract available

JIANG J , Liang X, Zhou X, Huang R, et al
DNA Repair Gene X-Ray Repair Cross Complementing Group 1 Arg194Trp Polymorphism on the Risk of Lung Cancer: A Meta-Analysis on 22 Studies.
J Thorac Oncol. 2010;5:1741-7.
PubMed Text format Related articles Abstract available

OHTSUKA K , Ohnishi H, Morii T, Fujiwara M, et al
Downregulated ABCG2 Enhances Sensitivity to Topoisomerase I Inhibitor in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1726-33.
PubMed Text format Related articles Abstract available

VANSTEENKISTE JF , Shepherd FA
The seventh tumor, node, metastasis staging system and lung cancer treatment choices: a matter of would, could, and should.
J Thorac Oncol. 2010;5:1724-5.
PubMed Text format Related articles

MAKINSON A , Pujol JL, Le Moing V, Reynes J, et al
Lung Cancer: An Emerging Epidemic in the human immunodeficiency virus-Infected Population.
J Thorac Oncol. 2010;5:1721-3.
PubMed Text format Related articles

HIRSCH FR
November - lung cancer awareness month!
J Thorac Oncol. 2010;5:1719-20.
PubMed Text format Related articles

WOODY NM , Djemil T, Adelstein DJ, Mason DP, et al
Severe local toxicity after lung stereotactic body radiation therapy: lesional abscess leading to bronchocutaneous fistula requiring surgical marsupialization.
J Thorac Oncol. 2010;5:1874-5.
PubMed Text format Related articles

GENEBES C , Brouchet L, Kamar N, Lepage B, et al
Characteristics of thoracic malignancies that occur after solid-organ transplantation.
J Thorac Oncol. 2010;5:1789-95.
PubMed Text format Related articles Abstract available

KAYTON ML , He M, Zakowski MF, Moreira AL, et al
Primary lung adenocarcinomas in children and adolescents treated for pediatric malignancies.
J Thorac Oncol. 2010;5:1764-71.
PubMed Text format Related articles Abstract available

KEMP CD , Kitano M, Kerkar S, Ripley RT, et al
Pulmonary resection for metastatic gastric cancer.
J Thorac Oncol. 2010;5:1796-805.
PubMed Text format Related articles Abstract available

LEE SY , Kim MJ, Jin G, Yoo SS, et al
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
J Thorac Oncol. 2010;5:1734-40.
PubMed Text format Related articles Abstract available

October 2010

KIM IS , Lee GW, Kim DC, Kim HG, et al
Polymorphisms and Haplotypes in the XRCC1 Gene and the Risk of Advanced Non-Small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LEIGHL NB , Zatloukal P, Mezger J, Ramlau R, et al
Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL).
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SCHILLER JH , von Pawel J, Schutt P, Ansari RH, et al
Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LIMA JP , Dos Santos LV, Sasse EC, Lima CS, et al
Camptothecins Compared with Etoposide in Combination with Platinum Analog in Extensive Stage Small Cell Lung Cancer: Systematic Review with Meta-Analysis.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

GANDARA DR , Grimminger P, Mack PC, Lara PN Jr, et al
Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

ZAUDERER M , Krug LM, Pietanza MC, O'Rourke D, et al
Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.
J Thorac Oncol. 2010;5:1716-7.
PubMed Text format Related articles

PIRKER R , Herth FJ, Kerr KM, Filipits M, et al
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
J Thorac Oncol. 2010;5:1706-13.
PubMed Text format Related articles Abstract available

HOTTA K , Kiura K, Takigawa N, Yoshioka H, et al
Desire for information and involvement in treatment decisions: lung cancer patients' preferences and their physicians' perceptions: results from Okayama Lung Cancer Study Group Trial 0705.
J Thorac Oncol. 2010;5:1668-72.
PubMed Text format Related articles Abstract available

BIDOLI P , Cortinovis DL, Colombo I, Crippa A, et al
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer.
J Thorac Oncol. 2010;5:1662-3.
PubMed Text format Related articles Abstract available

OTTERSON GA , Hodgson L, Pang H, Vokes EE, et al
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304).
J Thorac Oncol. 2010;5:1644-8.
PubMed Text format Related articles Abstract available

PRICE KA , Azzoli CG, Krug LM, Pietanza MC, et al
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
J Thorac Oncol. 2010;5:1623-9.
PubMed Text format Related articles Abstract available

STEINFORT DP , Liew D, Conron M, Hutchinson AF, et al
Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
J Thorac Oncol. 2010;5:1564-70.
PubMed Text format Related articles Abstract available

PATZ EF JR , Caporaso NE, Dubinett SM, Massion PP, et al
National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specim
J Thorac Oncol. 2010;5:1502-6.
PubMed Text format Related articles

ZWITTER M
Combining cytotoxic and targeted therapies for lung cancer.
J Thorac Oncol. 2010;5:1498-9.
PubMed Text format Related articles

EBERHARDT W
Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
J Thorac Oncol. 2010;5:1495-7.
PubMed Text format Related articles

BLASBERG JD , Pass HI, Donington JS
Sublobar resection: a movement from the Lung Cancer Study Group.
J Thorac Oncol. 2010;5:1583-93.
PubMed Text format Related articles Abstract available

SASAKI H , Yano M, Fujii Y
Evaluation of Kras gene mutation and copy number in thymic carcinomas and thymomas.
J Thorac Oncol. 2010;5:1715-6.
PubMed Text format Related articles

FUJIOKA N , French CA, Cameron MJ, Kratzke RA, et al
Long-term survival of a patient with squamous cell carcinoma harboring NUT gene rearrangement.
J Thorac Oncol. 2010;5:1704-5.
PubMed Text format Related articles

SCHUURBIERS OC , Looijen-Salamon MG, Ligtenberg MJ, van der Heijden HF, et al
A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.
J Thorac Oncol. 2010;5:1664-7.
PubMed Text format Related articles Abstract available

DETTERBECK FC
Sublobar resection: are the answers different or is it the questions?
J Thorac Oncol. 2010;5:1500-1.
PubMed Text format Related articles

September 2010

CASEY EM , Harb W, Bradford D, Bufill J, et al
Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaive Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KAWASE A , Yoshida J, Ishii G, Hishida T, et al
Visceral Pleural Invasion Classification in Non-Small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

GITLITZ BJ , Moon J, Glisson BS, Reimers HJ, et al
Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

DAI J , Jin G, Dong J, Chen Y, et al
Prognostic Significance of Survivin Polymorphisms on Non-small Cell Lung Cancer Survival.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

CLEMENT-DUCHENE C , Krupitskaya Y, Ganjoo K, Lavori P, et al
A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

STEWART DJ , Johnson C, Lopez A, Glisson B, et al
Extensive Disease Small Cell Lung Cancer Dose-Response Relationships: Implications for Resistance Mechanisms.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

PAKKALA S , Ramalingam SS
Lung Cancer in HIV-Positive Patients.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SUGA JM , Nguyen DV, Mohammed SM, Brown M, et al
Racial Disparities on the Use of Invasive and Noninvasive Staging in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HAURA EB , Sommers E, Song L, Chiappori A, et al
A Pilot Study of Preoperative Gefitinib for Early-Stage Lung Cancer to Assess Intratumor Drug Concentration and Pathways Mediating Primary Resistance.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LAN CC , Wu HC, Lee CH, Huang SF, et al
Lung cancer with unusual presentation as a thin-walled cyst in a young nonsmoker.
J Thorac Oncol. 2010;5:1481-2.
PubMed Text format Related articles

BECKER A , van Wijk A, Smit EF, Postmus PE, et al
Side-Effects of Long-Term Administration of Erlotinib in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1477-80.
PubMed Text format Related articles Abstract available

MATSUBARA D , Ishikawa S, Oguni S, Aburatani H, et al
Molecular Predictors of Sensitivity to the MET Inhibitor PHA665752 in Lung Carcinoma Cells.
J Thorac Oncol. 2010;5:1317-24.
PubMed Text format Related articles Abstract available

RYU JH
Chemotherapy-induced pulmonary toxicity in lung cancer patients.
J Thorac Oncol. 2010;5:1313-4.
PubMed Text format Related articles

IWASAKI T , Ohta M, Kawahara K
Pulmonary pleomorphic carcinoma: diagnosis using small biopsy specimens.
J Thorac Oncol. 2010;5:1492.
PubMed Text format Related articles

YOH K , Kenmotsu H, Yamaguchi Y, Kubota K, et al
Severe interstitial lung disease associated with amrubicin treatment.
J Thorac Oncol. 2010;5:1435-8.
PubMed Text format Related articles Abstract available

August 2010

MOK T , Wu YL, Au JS, Zhou C, et al
Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HATA A , Yoshioka H, Fujita S, Kunimasa K, et al
Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SUK HEIST R , Fain J, Chinnasami B, Khan W, et al
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NOVELLO S , Pimentel FL, Douillard JY, O'brien M, et al
Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaive Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

HAINSWORTH JD , Cebotaru CL, Kanarev V, Ciuleanu TE, et al
A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

AL-SAAD S , Al-Shibli K, Donnem T, Andersen S, et al
Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

OTSUKA H , Ishii G, Yoshida J, Yamaguchi Y, et al
Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NAKAO M , Yoshida J, Ishii G, Kawase A, et al
Prognostic Impact of Node Involvement Pattern in pN1 Non-small Cell Lung Cancer Patients.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SAKURAI H , Asamura H, Goya T, Eguchi K, et al
Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

RECK M , van Zandwijk N, Gridelli C, Baliko Z, et al
Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

AGULLO-ORTUNO MT , Lopez-Rios F, Paz-Ares L
Lung Cancer Genomic Signatures.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KATO Y , Peled N, Wynes MW, Yoshida K, et al
Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-Small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

GOPARAJU CM , Pass HI, Blasberg JD, Hirsch N, et al
Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SANDLER A , Yi J, Dahlberg S, Kolb MM, et al
Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

READY N , Janne PA, Bogart J, Dipetrillo T, et al
Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KANG CH
Differences of Gene Expression in Non-small Cell Lung Cancer: Are Histology, Tumor Site, and Methodology Relevant?
J Thorac Oncol. 2010;5:1311.
PubMed Text format Related articles

TOFFALORIO F , De Pas T, Giovannetti E
Differences of Gene Expression in Non-small Cell Lung Cancer: Are Histology, Tumor Site, and Methodology Relevant?
J Thorac Oncol. 2010;5:1310-1.
PubMed Text format Related articles

MADDISON P , Silcocks P
Prospective study of lambert-eaton myasthenic syndrome in small cell lung cancer.
J Thorac Oncol. 2010;5:1309-10.
PubMed Text format Related articles

TANIZAWA K , Sakamoto J, Hashimoto S, Misaki T, et al
Chylopericardium Caused by Non-small Cell Lung Cancer: A Rare Complication of Superior Vena Cava Syndrome.
J Thorac Oncol. 2010;5:1303-4.
PubMed Text format Related articles

LEE P , Colt HG
Bronchoscopy in lung cancer: appraisal of current technology and for the future.
J Thorac Oncol. 2010;5:1290-300.
PubMed Text format Related articles Abstract available

JOHN VJ , Jacobson MS, Grossniklaus HE
Bilateral choroidal metastasis as the presenting sign of small cell lung carcinoma.
J Thorac Oncol. 2010;5:1289.
PubMed Text format Related articles

BLACKHALL FH , O'brien M, Schmid P, Nicolson M, et al
A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1285-1288.
PubMed Text format Related articles Abstract available

HATA A , Katakami N, Fujita S, Kaji R, et al
Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma.
J Thorac Oncol. 2010;5:1197-200.
PubMed Text format Related articles Abstract available

ZHU X , Guo Y, Li X, Ding Y, et al
Metastasis-Associated Protein 1 Nuclear Expression is Associated with Tumor Progression and Clinical Outcome in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:1159-66.
PubMed Text format Related articles Abstract available

LEE SY , Choi YY, Choi JE, Kim MJ, et al
Polymorphisms in the caspase genes and the risk of lung cancer.
J Thorac Oncol. 2010;5:1152-8.
PubMed Text format Related articles Abstract available

July 2010

SAWABATA N , Asamura H, Goya T, Mori M, et al
Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SEGAWA Y , Kiura K, Hotta K, Takigawa N, et al
A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 05
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NAKAMURA Y , Sano K, Soda H, Takatani H, et al
Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

ZHAN P , Wang Q, Wei SZ, Wang J, et al
ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk: A Meta-Analysis Involving 22 Case-Control Studies.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

ADJEI AA , Salavaggione OE, Mandrekar SJ, Dy GK, et al
Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer: A North Central Cancer Treatment Group-Based Exploratory Study.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

BRUNETTO AT , Carden CP, Myerson J, Faria AL, et al
Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LEIGHL NB , Raez LE, Besse B, Rosen PJ, et al
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung.
J Thorac Oncol. 2010;5:1054-9.
PubMed Text format Related articles Abstract available

KANICK SC , van der Leest C, Djamin RS, Janssens AM, et al
Characterization of mediastinal lymph node physiology in vivo by optical spectroscopy during endoscopic ultrasound-guided fine needle aspiration.
J Thorac Oncol. 2010;5:981-7.
PubMed Text format Related articles Abstract available

KIM YH , Mishima M, Miyagawa-Hayashino A
Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab.
J Thorac Oncol. 2010;5:1107-8.
PubMed Text format Related articles

CHANG SC , Chang CY, Chen CY, Yu CJ, et al
Successful erlotinib rechallenge after gefitinib-induced acute interstitial pneumonia.
J Thorac Oncol. 2010;5:1105-6.
PubMed Text format Related articles

TAKEDA M , Okamoto I, Makimura C, Fukuoka M, et al
Successful treatment with erlotinib after gefitinib-induced severe interstitial lung disease.
J Thorac Oncol. 2010;5:1103-4.
PubMed Text format Related articles

DEVISETTY K , Salama JK
Tumor necrosis and cavitation after stereotactic body radiation therapy.
J Thorac Oncol. 2010;5:1100-2.
PubMed Text format Related articles

PETRELLA F , Rizzo S, Pelosi G, Borri A, et al
Giant alveolar adenoma causing severe dyspnoea.
J Thorac Oncol. 2010;5:1088-90.
PubMed Text format Related articles

YEO WL , Riely GJ, Yeap BY, Lau MW, et al
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.
J Thorac Oncol. 2010;5:1048-53.
PubMed Text format Related articles Abstract available

YOO SB , Chung JH, Lee HJ, Lee CT, et al
Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
J Thorac Oncol. 2010;5:964-9.
PubMed Text format Related articles Abstract available

SIVA S , MacManus M, Ball D
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
J Thorac Oncol. 2010;5:1091-9.
PubMed Text format Related articles Abstract available

TANVETYANON T , Robinson L, Sommers KE, Haura E, et al
Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers.
J Thorac Oncol. 2010;5:1018-24.
PubMed Text format Related articles Abstract available

June 2010

Molecular origins of lung cancer - prospects for personalized prevention and therapy. Proceedings and abstracts of a meeting. January 10-14, 2010. San Diego, California, USA.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

TREASURE T , Fallowfield L, Lees B
Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

UTLEY M , Treasure T
Interpreting data from surgical follow-up studies: the role of modeling.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

PASTORINO U
The development of an international registry.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

FIORENTINO F , Treasure T
A plea for consistency in the reporting of surgical series illustrated with an analysis of 51 follow-up reports of pulmonary metastasectomy in colorectal carcinoma.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

OLIARO A , Filosso PL, Bruna MC, Mossetti C, et al
Pulmonary metastasectomy for melanoma.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

PFANNSCHMIDT J , Hoffmann H, Dienemann H
Thoracic metastasectomy for nonseminomatous germ cell tumors.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

TREASURE T
Carcinoma embryonic antigen: its place in decision making for pulmonary metastasectomy in colorectal cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

PFANNSCHMIDT J , Hoffmann H, Dienemann H
Reported outcome factors for pulmonary resection in metastatic colorectal cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

GARCIA-YUSTE M , Cassivi S, Paleru C
Pulmonary metastasectomy in breast cancer.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

GARCIA-YUSTE M , Cassivi S, Paleru C
Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

DETTERBECK F
The number of metastases and its influence on outcome: editorial comment.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

MIGLIORE M , Jakovic R, Hensens A, Klepetko W, et al
Extending surgery for pulmonary metastasectomy: what are the limits?
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

VAN SCHIL PE , Furrer M, Friedel G
Locoregional therapy.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

VENUTA F , Rolle A, Anile M, Martucci N, et al
Techniques used in lung metastasectomy.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

MOLNAR TF , Gebitekin C, Turna A
What are the considerations in the surgical approach in pulmonary metastasectomy?
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

DETTERBECK FC , Grodzki T, Gleeson F, Robert JH, et al
Imaging requirements in the practice of pulmonary metastasectomy.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

PASTORINO U , Treasure T
A historical note on pulmonary metastasectomy.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

RUSCH VW
Pulmonary metastasectomy: a moving target.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles

VAN RAEMDONCK D , Friedel G
The European Society of Thoracic Surgeons lung metastasectomy project.
J Thorac Oncol. 2010;5.
PubMed Text format Related articles Abstract available

CASALI C , Rossi G, Marchioni A, Sartori G, et al
A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
J Thorac Oncol. 2010;5:830-6.
PubMed Text format Related articles Abstract available

TOGASHI Y , Masago K, Mishima M, Fukudo M, et al
A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.
J Thorac Oncol. 2010;5:924-5.
PubMed Text format Related articles

IRSHAD S , McLean E, Rankin S, Barrington S, et al
Unilateral diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and multiple carcinoids treated with surgical resection.
J Thorac Oncol. 2010;5:921-3.
PubMed Text format Related articles

POP D , Nadeemy AS, Venissac N, Guiraudet P, et al
Late mediastinal hematoma followed by incisional metastasis after video-assisted mediastinoscopy.
J Thorac Oncol. 2010;5:919-20.
PubMed Text format Related articles

HIRA HS , Shukla A, Chhabra G, Saran RK, et al
Yolk sac tumor and Horner's syndrome-a case report.
J Thorac Oncol. 2010;5:917-8.
PubMed Text format Related articles

SASAKI H , Hikosaka Y, Okuda K, Kawano O, et al
NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung.
J Thorac Oncol. 2010;5:786-9.
PubMed Text format Related articles Abstract available

May 2010

DETTERBECK FC
A systematic review but systematically confounded?
J Thorac Oncol. 2010;5:754-6.
PubMed Text format Related articles

NAGOVSKIY N , Agarwal M, Allerton J
Cetuximab-induced aseptic meningitis.
J Thorac Oncol. 2010;5:751.
PubMed Text format Related articles

LEE HJ , Choe G, Jheon S, Sung SW, et al
CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
J Thorac Oncol. 2010;5:649-57.
PubMed Text format Related articles Abstract available

LUSTBERG MB , Bekaii-Saab T, Young D, Otterson G, et al
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
J Thorac Oncol. 2010;5:713-8.
PubMed Text format Related articles Abstract available

ONITSUKA T , Uramoto H, Ono K, Takenoyama M, et al
Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
J Thorac Oncol. 2010;5:591-6.
PubMed Text format Related articles Abstract available

April 2010

TAKAO M , Takagi T, Suzuki H, Shimamoto A, et al
Resection of mucinous lung adenocarcinoma presenting with intractable bronchorrhea.
J Thorac Oncol. 2010;5:576-8.
PubMed Text format Related articles

BERTHOD G , Bouzourene H, Pachinger C, Peters S, et al
Solitary choriocarcinoma in the lung.
J Thorac Oncol. 2010;5:574-5.
PubMed Text format Related articles

TAGAWA T , Ohta M, Kuwata T, Awaya H, et al
S-1 plus cisplatin chemotherapy with concurrent radiation for thymic basaloid carcinoma.
J Thorac Oncol. 2010;5:572-3.
PubMed Text format Related articles

YOSHIDA J , Ishii G, Yokose T, Aokage K, et al
Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients.
J Thorac Oncol. 2010;5:546-50.
PubMed Text format Related articles Abstract available

MAESHIMA AM , Tochigi N, Yoshida A, Asamura H, et al
Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence.
J Thorac Oncol. 2010;5:466-71.
PubMed Text format Related articles Abstract available

GARFIELD D , Normanno N
Osteoblastosis and activating epidermal growth factor receptor mutations: a relationship?
J Thorac Oncol. 2010;5:415-6.
PubMed Text format Related articles

LOO PS , Thomas SC, Nicolson MC, Fyfe MN, et al
Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
J Thorac Oncol. 2010;5:442-7.
PubMed Text format Related articles Abstract available

OU SH , Ziogas A, Zell JA
Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
J Thorac Oncol. 2010;5:420-7.
PubMed Text format Related articles Abstract available

COGHLIN CL , Smith LJ, Bakar S, Stewart KN, et al
Quantitative analysis of tumor in bronchial biopsy specimens.
J Thorac Oncol. 2010;5:448-52.
PubMed Text format Related articles Abstract available

HOSHI R , Furuta N, Horai T, Ishikawa Y, et al
Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma from small cell carcinoma of the lung.
J Thorac Oncol. 2010;5:472-8.
PubMed Text format Related articles Abstract available

KAIRA K , Horie Y, Ayabe E, Murakami H, et al
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
J Thorac Oncol. 2010;5:460-5.
PubMed Text format Related articles Abstract available

NAKAO M , Yoshida J, Ishii G, Hishida T, et al
Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients.
J Thorac Oncol. 2010;5:504-9.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: